WKHS Locations

Clinical Trials

  • 11SI Pediatric Constipation

    To evaluate the long term safety and efficacy of Lubiprostone 12 or 24 mcg twice daily.

  • 1131 Pediatric Constipation

    To evaluate the safety and efficacy of Lubiprostone 12 or 24 mcg twice daily compared to placebo.

  • BUP 3031

    To characterize the safety and the pharmacokinetics (PK) of BTDS in patients of ages 7 to 16 years,inclusive, who require continuous opioid analgesia for moderate to severe pain.